185 related articles for article (PubMed ID: 36358686)
1. Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor-Induced Kidney Injury.
Abudayyeh A; Suo L; Lin H; Mamlouk O; Abdel-Wahab N; Tchakarov A
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358686
[TBL] [Abstract][Full Text] [Related]
2. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
Hakroush S; Kopp SB; Tampe D; Gersmann AK; Korsten P; Zeisberg M; Tampe B
Front Immunol; 2020; 11():624547. PubMed ID: 33552089
[TBL] [Abstract][Full Text] [Related]
3. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
Baker ML; Yamamoto Y; Perazella MA; Dizman N; Shirali AC; Hafez N; Weinstein J; Simonov M; Testani JM; Kluger HM; Cantley LG; Parikh CR; Wilson FP; Moledina DG
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35354588
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study.
Bao Z; Luo L; Xu T; Yang J; Lv M; Ni L; Sun X; Chen W; Zhou L; Wang X; Xiang Y; Gao B
Ann Transl Med; 2022 Sep; 10(18):967. PubMed ID: 36267724
[TBL] [Abstract][Full Text] [Related]
5. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis.
Miao J; Herrmann SM
Clin Kidney J; 2023 Nov; 16(11):1834-1844. PubMed ID: 37915905
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease.
Seethapathy H; Mistry K; Sise ME
Immunol Rev; 2023 Sep; 318(1):61-69. PubMed ID: 37482912
[TBL] [Abstract][Full Text] [Related]
8. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.
Elghawy O; Patel R; Barsouk A; Puthumana J; Xu J; Sussman J; Horton B; Kaur V
J Oncol Pharm Pract; 2024 May; ():10781552241252627. PubMed ID: 38706192
[TBL] [Abstract][Full Text] [Related]
10. Serum sodium levels associate with recovery of kidney function in immune checkpoint inhibitor nephrotoxicity.
Tampe D; Baier E; Hakroush S; Tampe B
Front Med (Lausanne); 2023; 10():1020691. PubMed ID: 37547603
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of Intrarenal Programmed Cell Death Protein 1-Ligand 1 and Its Receptor in Kidney Injury Related to Immune Checkpoint Inhibitor Nephrotoxicity.
Tampe D; Kopp SB; Baier E; Hakroush S; Tampe B
Front Med (Lausanne); 2022; 9():902256. PubMed ID: 35755033
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
Tan HZ; Sprangers B
Clin Kidney J; 2023 Nov; 16(11):1709-1713. PubMed ID: 37915924
[TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis.
Singh S; Long JP; Tchakarov A; Dong Y; Yee C; Lin JS
JCI Insight; 2022 Dec; ():. PubMed ID: 36472921
[TBL] [Abstract][Full Text] [Related]
14. Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma.
Patel V; Elias R; Formella J; Schwartzman W; Christie A; Cai Q; Malladi V; Kapur P; Vazquez M; McKay R; Pedrosa I; Hannan R; Hammers H; Brugarolas J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33139246
[TBL] [Abstract][Full Text] [Related]
15. Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report.
Tanabe K; Matsuoka-Uchiyama N; Mifune T; Kawakita C; Sugiyama H; Wada J
Medicine (Baltimore); 2021 Dec; 100(50):e28252. PubMed ID: 34918693
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.
Kitchlu A; Jhaveri KD; Wadhwani S; Deshpande P; Harel Z; Kishibe T; Henriksen K; Wanchoo R
Kidney Int Rep; 2021 Jan; 6(1):66-77. PubMed ID: 33426386
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report.
Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A
BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
Sise ME; Seethapathy H; Reynolds KL
Oncologist; 2019 Jun; 24(6):735-742. PubMed ID: 30902916
[TBL] [Abstract][Full Text] [Related]
19. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
[TBL] [Abstract][Full Text] [Related]
20. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]